Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides-Reference-Cited by-同舟云学术

Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides

Published:2015-05 Issue: Volume:206 Page:75-90
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Weng Alexander,Manunta Maria D.I.,Thakur Mayank,Gilabert-Oriol Roger,Tagalakis Aristides D.,Eddaoudi Ayad,Munye Mustafa M.,Vink Conrad A.,Wiesner Burkhard,Eichhorst Jenny,Melzig Matthias F.,Hart Stephen L.

Funder

The German Research Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. siRNA delivery: from lipids to cell-penetrating peptides and their mimics;Gooding;Chem. Biol. Drug Des.,2012

2. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic;Davis;Mol. Pharm.,2009

3. Folate receptor-targeted liposomes as vectors for therapeutic agents;Gosselin;Biotechnol. Annu. Rev.,2002

4. Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo;Choi;Mol. Pharm.,2013

5. The reconstructed ancestral subunit a functions as both V-ATPase isoforms Vph1p and Stv1p in Saccharomyces cerevisiae;Finnigan;Mol. Biol. Cell,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Broadening the Scope of Sapofection: Cationic Peptide-Saponin Conjugates Improve Gene Delivery In Vitro and In Vivo;ACS Applied Materials & Interfaces;2024-07-06

2. Food-Derived Peptides: Beneficial CNS Effects and Cross-BBB Transmission Strategies;Journal of Agricultural and Food Chemistry;2023-12-12

3. Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate Cancer;Journal of Cancer;2023

4. Gene therapy: Comprehensive overview and therapeutic applications;Life Sciences;2022-04

5. Suicide nanoplasmids coding for ribosome-inactivating proteins;European Journal of Pharmaceutical Sciences;2022-03